Nojima, T., Matsubayashi, Y., Yoshida, A., Suganami, H., Abe, T., Ishizawa, M., . . . Sone, H. (2020). Influence of an SGLT2 inhibitor, tofogliflozin, on the resting heart rate in relation to adipose tissue insulin resistance. Diabet Med.
Style de citation ChicagoNojima, T., et al. "Influence of an SGLT2 Inhibitor, Tofogliflozin, On the Resting Heart Rate in Relation to Adipose Tissue Insulin Resistance." Diabet Med 2020.
Style de citation MLANojima, T., et al. "Influence of an SGLT2 Inhibitor, Tofogliflozin, On the Resting Heart Rate in Relation to Adipose Tissue Insulin Resistance." Diabet Med 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.